iThe current values are delayed, open demat account for live values.
BSE Diversified RevGrowth
BSE Diversified RevGrowth Performance
-
Open
1,540.41
-
High
1,546.08
-
Low
1,495.90
-
Prev Close
1,536.06
-
Dividend Yeild
0.52%
-
P/E
23.78

BSE Diversified RevGrowth Sector Performance
Top Performing
Sector Name | Percentage Change |
---|
Under Performing
Sector Name | Percentage Change |
---|---|
Diamond, Gems and Jewellery | -2.47 |
IT - Hardware | -1.87 |
Leather | -1.69 |
Ceramic Products | -2.56 |

Color code for Stocks Performance
- 5% and above
- 5% to 2%
- 2% to 0.5%
- 0.5% to -0.5%
- -0.5% to -2%
- -2% to -5%
- -5% and below
Constituent Companies
Company | Market Cap | Market Price | Volume | Sector |
---|---|---|---|---|
Bajaj Holdings & Investment Ltd | ₹135237 Cr |
₹12140
(1.08%)
|
3090 | Finance |
Tata Investment Corporation Ltd | ₹31073 Cr |
₹6141.5
(0.44%)
|
6539 | Finance |
Maharashtra Scooters Ltd | ₹13270 Cr |
₹11468
(1.46%)
|
606 | Finance |
Cholamandalam Financial Holdings Ltd | ₹37177 Cr |
₹1978
(0.03%)
|
8328 | Finance |
Can Fin Homes Ltd | ₹9633 Cr |
₹723.45
(1.66%)
|
24575 | Finance |
Other Indices
Indices Name | Price | Price Change (% change) |
---|---|---|
India VIX | 17.1575 | 0.91 (5.58%) |
Nifty 10 Yr Benchmark G-Sec | 2564.89 | -2.14 (-0.08%) |
Nifty 10 Yr Benchmark G-Sec (Clean Price) | 914.38 | -0.93 (-0.1%) |
Nifty 100 | 24581.3 | -279.6 (-1.12%) |
Nifty 100 Alpha 30 Index | 16982.7 | -342.75 (-1.98%) |
Latest News

- Apr 25, 2025
The Indian pharmaceutical industry is experiencing a somewhat turbulent period. With the United States considering imposing tariffs on imported goods—including essential medicines—the future of India's thriving generic drug sector hangs in the balance. While India's drug manufacturers have so far been spared from recent U.S. tariff announcements, there's still concern over what could happen. After all, India supplies nearly half of America's generic drugs.

- Apr 25, 2025
Reliance Industries Ltd (RIL), led by Mukesh Ambani, is set to announce its financial results for the fourth quarter (Q4 FY25) and the full year ended March 31, 2025, on Friday, April 25. According to a Moneycontrol survey of eight analysts, the conglomerate is expected to post mixed results, with gains in its digital and retail businesses offset by weakness in its oil-to-chemicals (O2C) and upstream oil and gas segments.
Latest Blogs
Choosing the right Systematic Investment Plan (SIP) is one of the smartest ways to build long-term wealth, but with countless options available, how do you know which SIP is best for you? The right SIP plan aligns with your financial goals, risk appetite, and investment horizon while offering optimal returns.
- Apr 27, 2025

Nifty Prediction NIFTY closed lower today, dragged by broadbased selling across sectors. IT was the only bright spot as it stayed afloat on positive cues from US markets. A stark advance-decline ratio of 0.2 highlights the broad-based weakness. SHRIRAMFIN was the top loser and was down 8%. On the other hand, SBILIFE was the top performer (up 5.2%). Geopolitical Tensions Rattle D-Street
- Apr 25, 2025
